Neuro20 Technologies Corp.
PrivateLast Round
Seed
May 1, 2022
Total Funding Raised
$1.31M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Neuro20 Technologies Corp. operates in Healthcare & Life Sciences and is based in Oldsmar, Florida. Its latest recorded funding round was a Seed round in May 2022.
Neuro20 Technologies Corp. is a medical device company that develops and manufactures wearable neuromuscular stimulation systems for rehabilitation and physical performance.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Health IoT, Sports & Fitness
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Neuro20 Technologies Corp. Comparables
Compare Neuro20 Technologies Corp. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AxioBionics | 78% | |
| Wiemspro | 74% | |
| CIONIC | 71% |
For institutional investors. Book with your work email.
Neuro20 Technologies Corp. Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Neuro20 Technologies Corp. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| IntuitiveX | Seed |
| Tampa Bay Technology Incubator | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 13, 2026
Monthly visitors increased 283% MoM, reaching 1.3K.
- Dec 21, 2023
Grew 25% QoQ, from 12 to 15 employees.
For institutional investors. Book with your work email.
Neuro20 Technologies Corp. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Neuro20 Technologies Corp.'s valuation, stock price, and market status.
Is Neuro20 Technologies Corp. a public or private company?
Neuro20 Technologies Corp. is a private company.
What is the current stock price of Neuro20 Technologies Corp.?
Neuro20 Technologies Corp. is a private company, so its shares have no public market price. Caplight tracks Neuro20 Technologies Corp.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Neuro20 Technologies Corp. worth (valuation)?
Valuation information for Neuro20 Technologies Corp. is not publicly available.
Can I buy Neuro20 Technologies Corp. stock?
Neuro20 Technologies Corp. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Neuro20 Technologies Corp.'s last funding round?
Neuro20 Technologies Corp.'s most recent funding round was Seed on May 1, 2022.
Who are the main investors in Neuro20 Technologies Corp.?
Key investors in Neuro20 Technologies Corp. include IntuitiveX, Tampa Bay Technology Incubator.
Will Neuro20 Technologies Corp. IPO soon?
No public IPO plans have been announced for Neuro20 Technologies Corp..
How can I track Neuro20 Technologies Corp. secondary market activity?
Caplight tracks bids, offers, and trades in Neuro20 Technologies Corp.'s shares on secondary markets.